Clinical Trials Browser

OTHER_GOV × Interventional × Esophageal Neoplasms × Clear all

NCT07482566 2026-03-20

SIEWERT-RCT

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT05875870 2026-02-17

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Phase NA Recruiting

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT07332221 2026-01-12

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Phase 3 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07188103 2025-09-23

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03161535 2025-07-28

Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal Cancer

Phase NA Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07034118 2025-06-24

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

Phase 1 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06979986 2025-05-20

SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06692270 2025-02-28

Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06365866 2024-04-15

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Phase NA Unknown

GastrointestinalHead & Neck

Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05624099 2023-10-19

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Phase 2 Recruiting

Gastrointestinal

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

NCT04188990 2023-09-21

Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition

Phase NA Completed

Gastrointestinal

Colitis, Ulcerative, Crohn Disease, Esophageal Neoplasms, Pancreatic Neoplasms, Pancreatitis, Stomach Neoplasms, Colorectal Neoplasms, Inflammatory Bowel Diseases

NCT06037902 2023-09-14

TROS-7

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05688020 2023-08-09

Tranexamic Acid During Upper GI Endoscopic Resection Procedures

Phase 4 Unknown

Gastrointestinal

Polyposis, Gastric, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT02395705 2022-10-05

Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma

Phase 3 Completed

Gastrointestinal

Esophageal Neoplasms

NCT04280822 2022-10-04

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT04316078 2022-04-28

A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies

Phase NA Completed

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05007145 2021-12-21

REVO

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05013697 2021-08-19

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT03719716 2021-03-09

GI-ACP

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03413436 2020-08-28

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms

NCT03110939 2020-01-22

Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer

Phase NA Withdrawn

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT03985670 2019-12-12

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04158414 2019-11-08

Applying PET/MR in Oncology - a Prospective Project

Phase NA Unknown

GastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcoma

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lymphoma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT01915693 2019-06-04

ROCS

Phase 3 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02611245 2018-06-08

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG

Phase 1 Completed

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT02924909 2018-03-20

QUIMERA

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT01998230 2015-10-16

Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer

Phase 3 Completed

Gastrointestinal

Esophageal Neoplasms

NCT01843829 2014-03-24

NeoSCOPE

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00665197 2011-10-13

Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia

Phase 3 Completed

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

NCT00453323 2010-07-12

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00559351 2007-11-16

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Phase 3 Terminated

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Squamous Cell

NCT00193817 2006-02-07

Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial

Phase 3 Unknown

Gastrointestinal

Esophageal Neoplasms, Neoplasms